Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2020-04-03 Director's Dealing
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2020-04-03 English
PRIMARY DOCUMENT
Director's Dealing
2020-04-01 English
PRIMARY DOCUMENT
Director's Dealing
2020-04-01 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement related to shareholder meetings. It specifically mentions additional information regarding the Annual Meeting of Stockholders, including details about the meeting format (virtual), voting instructions, and how shareholders can participate. It is labeled as "Definitive Additional Materials" to the proxy statement, not the proxy statement itself. The content focuses on meeting logistics and shareholder voting, not on the full proxy statement or the actual voting results. This type of document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is not an announcement of voting results (DVA), nor is it a full Annual Report or other financial report. Therefore, the correct classification is PSI with high confidence.
2020-03-31 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content details Baxter International Inc.'s entry into a material definitive agreement involving the issuance of senior notes (debt financing), including the terms of the indenture, supplemental indenture, and registration rights agreement. The document focuses on financing activities, specifically the issuance of senior notes and related agreements. There are no financial statements or comprehensive financial performance data included, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a proxy, earnings release, or management discussion. The primary subject is the company's capital raising through debt issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains detailed information about the financing transaction, supporting a high confidence score.
2020-03-27 English
PRIMARY DOCUMENT
Director's Dealing
2020-03-23 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.